ATHENIUM Trademark

Trademark Overview

On Wednesday, September 6, 2023, a trademark application was filed for ATHENIUM with the United States Patent and Trademark Office. The USPTO has given the ATHENIUM trademark a serial number of 98166759. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Tuesday, August 5, 2025. This trademark is owned by Danco Investors Group, L.P.. The ATHENIUM trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical services, namely, research and development services of new pharmaceutical products
athenium

General Information

Serial Number98166759
Word MarkATHENIUM
Filing DateWednesday, September 6, 2023
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateTuesday, August 5, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 26, 2025

Trademark Statements

Goods and ServicesPharmaceutical services, namely, research and development services of new pharmaceutical products

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, September 28, 2023
Primary Code042
First Use Anywhere DateMonday, March 18, 2002
First Use In Commerce DateMonday, March 18, 2002

Trademark Owner History

Party NameDanco Investors Group, L.P.
Party Type10 - Original Applicant
Legal Entity Type13 - Limited Partnership
AddressNashville, TN 37215

Trademark Events

Event DateEvent Description
Saturday, September 9, 2023NEW APPLICATION ENTERED
Thursday, September 28, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, May 1, 2024ASSIGNED TO EXAMINER
Monday, May 6, 2024NON-FINAL ACTION E-MAILED
Monday, May 6, 2024NON-FINAL ACTION WRITTEN
Friday, July 19, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Monday, May 6, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, July 19, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Wednesday, November 6, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 6, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 2, 2024NON-FINAL ACTION WRITTEN
Monday, December 2, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, November 6, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, January 16, 2025NON-FINAL ACTION E-MAILED
Monday, December 2, 2024NON-FINAL ACTION E-MAILED
Thursday, January 16, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, February 7, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, February 7, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 5, 2025APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Wednesday, March 5, 2025APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Wednesday, July 16, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, July 17, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 16, 2025NON-FINAL ACTION WRITTEN
Friday, February 7, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, July 16, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, July 18, 2025APPROVED FOR PUB - PRINCIPAL REGISTER

Related Keywords

athenium pharmaceutical services products development namely research